Dopa-Responsive Dystonia:Long-Term Treatment Response and Prognosis
Neurol 41:174-181, Nygaard,T.G.,et al, 1991
Early Combination of Selegiline and Low-Dose Levodopa as Initial Symptomatic Therapy in Parkinson's Dis
Arch Neurol 48:31-34, Elizan,T.S.,et al, 1991
Young-Onset Parkinson's Disease:A Clinical Review
Neurol 41:168-173, Golbe,L.I., 1991
Early Development of Levodopa-Induced Dyskinesias and Response Fluctuations in Young-Onset Parkinson's Disease
Neurol 41:202-205, Kostic,V., 1991
Presynaptic Parkinsonism in Olivopontocerebellar Atrophy:Clinical, pathological, and Neurochemical Evidence
Ann Neurol 30:425-428, Pascual,J.,et al, 1991
Neurologic Compliations of the Tryptophan-Associated Eosinophilia-Myalgia Syndrome
Arch Neurol 48:436-438, Tolander,L.M.,et al, 1991
Stereotactic Ventrolateralis Thalamotomy for Refractory Tremor in Post-Levodopa Era Parkinson's Dis
J Neurosurg 75:723-730, Fox,M.W.,et al, 1991
Stereotaxic Thalamotomy-Experiences from the Levodopa Era
JNNP 53:427-430, Wester,K.&Hauglie-Hanssen,E., 1990
L-Tryptophan-Induced Eosinophila-Myalgia Syndrome and Myopathy
Neurol 40:1629-1630, Sagman,D.L.&Melamed,J.C., 1990
Peripheral Neuropathy Associated with Eosinophilia-Myalgia Syndrome
Ann Neurol 28:522-528, Heiman-Patterson,T.D.,et al, 1990
Mononeuropathy Multiplex in Tryptophan-Associated Eosinophilia-Myalgia Syndrome
Neurol 40:1632-1633, Selwa,J.F.,et al, 1990
A Comparison of Effects of Controlled-Release Levodopa (Madopar CR) with Levodopa in Late Parkinson's Disease
JNNP 53:220-223, MacMahon,D.G.,et al, 1990
Scleroderma, fasciitis, and Eosinophilia Associated with the Ingestion of Tryptophan
NEJM 322:874-881, 9261990., Silver,R.M.,et al, 1990
Association of the Eosinophilia-Myalgia Syndrome with the Ingestion of Tryptophan
NEJM 322:869-873, 9261990., Hertzman,P.A.,et al, 1990
Tryptophan-Induced Eosinophilia-Myalgia Syndrome
NEJM 322:926-928, Medsger,T.A., 1990
Respiratory Dysfunction Due to L-Dopa Therapy for Parkinsonism:Diagnosis Using Serial Pulmonary Function Tests
Am J Med 89:109-114, Zupnick,H.M.,et al, 1990
Two Patients with Eosinophilia Myalgia Syndrome Associated with Tryptophan
BMJ 301:21, VanGarsse,L.G.M.&Boeykens,P.P.H., 1990
Peripheral Neuropathy in the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion
Neurol 40 1035-1040, Smith,B.E.&Dyck,P.J., 1990
The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion
Ann Int Med 113:124-134, Martin,R.W.,et al, 1990
L-Tryptophan-Associated Eosinophilic Perimyositis, Neuritis, and Fasciitis
Medicine 69:187-199, Kaufman,L.D.,et al, 1990
Sustained Enteral Administration of Levodopa Increases and Interrupted Infusion Decreases Levodopa Dose Requirements
Neurol 40:995-997, Cedarbaum,J.M.,et al, 1990
Decreased Efficacy of Levodopa with Carbidopa in Parkinsonian Patients after Adrenal-to-Caudate Implants
Neurol 40:845-846, Tsui,J.K.C.,et al, 1990
Right-Left Disorientation in Dementia of the Alzheimer Type
Neurol 40:1619-1620, Fischer,P.,et al, 1990
Cognitive Change Following MPTP Exposure
Neurol 40:261-264, Stern,Y.,et al, 1990
The Dystonias
BMJ 300:139-144, Marsden,C.D.&Quinn,N.P., 1990
Clinicopath Conf
Eosinophilic Fasciitis, Case Study 4-1990, NEJM 322:252-261, 93190., , 1990
Development of Diffuse Fasciitis with Eosinophilia During L-Tryptophan Treatment:Elevated Type I Collagen Gene
Ann Int Med 112:344-351, Varga,J.,et al, 1990
L-tryptophan and Eosinophilia-Myalgia Syndrome in New Mexico
Lancet 335:645-648, Eidson,M.,et al, 1990
Interim Guidance on the Eosinophilia-Myalgia Syndrome
Ann Int Med 112:85-87, Kilbourne,E.M.,et al, 1990
A Case of the Eosinophilia-Myalgia Syndrome Associated with Use of an L-Tryptophan
Ann Int Med 112:300-301, Flannery,M.T.,et al, 1990
Mortality Associated with Early and Late Levodopa Therapy Initiation in Parkinson's Disease
Neurol 40:265-269, Scigliano,G.,et al, 1990
Dopa-Responsive Dystonia:The Spectrum of Clinical Manifestations in a Large North American Family
Neurol 40:66-69, Nygaard,T.G.,et al, 1990
Levodopa-Induced Dyskinesia:Review, Observations, and Speculations
Neurol 40:340-345, Nutt,J.G., 1990
Selegiline as an Adjunct to Conventional Levodopa Therapy in Parkinson's Disease
Arch Neurol 46:1280-1283, Elizan,T.S.,et al, 1989
Swallowing Abnormalities and Their Response to Treatment in Parkinson's Disease
Neurol 39:1309-1314, Bushman,M.,et al, 1989
Drugs Acting on 5-Hydroxytryptamine Receptors
Editorial, Lancet 2:717-7191989., , 1989
Eosinophilia-Myalgia Syndrome-New Mexico
JAMA 262:3116, Belvins,W.L.,et al, 1989
Chronic Manganese Intoxication
Arch Neurol 46:1104-1106, Huang,C.C.,et al, 1989
Controlled Release of Dopamine from a Polymeric Brain Implant:In Vivo Characterization
Ann Neurol 25:351-356, During,M.J.,et al, 1989
Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989
A Double-Blind Crossover Comparison of Sinemet CR4 and Standard Sinemet 25/100 in Patients with Parkinson's Disease
JNNP 52:207-212, Cedarbaum,J.M.,et al, 1989
Efficacy of Sinemet CR4 in Subgroups of Patients with Parkinson's Disease
JNNP 52:83-88, Factor,S.A.,et al, 1989
Dose-Dependent Memory Impairment in Parkinson's Disease
Neurol 39:438-440, Huber,S.J.,et al, 1989
Continuous Levodopa Infusions to Treat Complex Dystonia in Parkinson's Disease
Neurol 39:888-891, Sage,J.I.,et al, 1989
Dopa Responsive Dystonia:A Treatable Condition Misdiagnosed as Cerebral Palsy
BMJ 298:1019-1020, Boyd,K.&Patterson,V., 1989
Amount and Distribution of Dietary Protein Affects Clinical Response to Levodopa in Parkinson's Disease
Neurol 39:552-556, Carter,J.H., 1989
The Effect of Dietary Protein on the Efficacy of L-Dopa:A Double-Blind Study
Neurol 39:549-552, Tsui,J.K.,et al, 1989
Diffuse Lewy Body Disease:Clinical Features in 15 Cases
JNNP 52:709-717, Byrne,E.J., 1989
Cerebrovascular Complications of L-Asparaginase Therapy
Neurol 38:127-133, Feinberg,W.M.&Swenson,M.R., 1988
International Symposium on Early Dopamine Agonist Therapy of Parkinson's Disease
Arch Neurol 45:204-208, Kurlan,R., 1988